These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2669199)

  • 1. Failure of tumor necrosis factor to produce hypotensive shock in the absence of endotoxin.
    Neilson IR; Neilson KA; Yunis EJ; Rowe MI
    Surgery; 1989 Aug; 106(2):439-43. PubMed ID: 2669199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat.
    Turner CR; Esser KM; Wheeldon EB; Slivjak M; Smith EF
    Circ Shock; 1989 Aug; 28(4):369-84. PubMed ID: 2673572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
    Sun XM; Hsueh W; Torre-Amione G
    Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine abrogates acute lung injury induced by endotoxin.
    Kao SJ; Wang D; Lin HI; Chen HI
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):33-40. PubMed ID: 16445696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension.
    Weinberg JR; Boyle P; Meager A; Guz A
    J Lab Clin Med; 1992 Aug; 120(2):205-11. PubMed ID: 1500820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats.
    Feuerstein G; Hallenbeck JM; Vanatta B; Rabinovici R; Perera PY; Vogel SN
    Circ Shock; 1990 Mar; 30(3):265-78. PubMed ID: 2178800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    Sun XM; Hsueh W
    J Immunol; 1991 Jul; 147(2):509-14. PubMed ID: 2071893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SK&F 86002 inhibits tumor necrosis factor formation and improves survival in endotoxemic rats.
    Smith EF; Slivjak MJ; Bartus JO; Esser KM
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):721-8. PubMed ID: 1723769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of post-treatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats.
    Taniguchi T; Takemoto Y; Tsuda K; Inaba H; Yamamoto K
    Blood Purif; 2006; 24(5-6):460-4. PubMed ID: 16953106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splanchnic and systemic hemodynamic responses to portal vein endotoxin after resuscitation from hemorrhagic shock.
    Gavin TJ; Fabian TC; Wilson JD; Trenthem LL; Pritchard FE; Croce MA; Stewart RM; Proctor KG
    Surgery; 1994 Mar; 115(3):310-24. PubMed ID: 8128356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloricromene, a coumarine derivative, protects against lethal endotoxin shock in rats.
    Squadrito F; Altavilla D; Campo GM; Calapai G; Ioculano M; Zingarelli B; Saitta A; Prosdocimi M; Caputi AP
    Eur J Pharmacol; 1992 Jan; 210(2):107-13. PubMed ID: 1601052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin.
    Hsueh W; Sun X; Rioja LN; Gonzalez-Crussi F
    Immunology; 1990 Jul; 70(3):309-14. PubMed ID: 2379939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats.
    Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative and interactive in vivo effects of tumor necrosis factor alpha and endotoxin.
    Ciancio MJ; Hunt J; Jones SB; Filkins JP
    Circ Shock; 1991 Feb; 33(2):108-20. PubMed ID: 2049814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model.
    Koga K; Ogata M; Takenaka I; Matsumoto T; Shigematsu A
    Circ Shock; 1994 Nov; 44(3):160-8. PubMed ID: 7600640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small volume resuscitation with 7.5% hypertonic saline, hydroxyethyl starch 130/0.4 solution and hypertonic sodium chloride hydroxyethyl starch 40 injection reduced lung injury in endotoxin shock rats: comparison with saline.
    Yu G; Chi X; Hei Z; Shen N; Chen J; Zhang W; Li S
    Pulm Pharmacol Ther; 2012 Feb; 25(1):27-32. PubMed ID: 22037283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor necrosis factor in endotoxic shock.
    Heidemann SM; Sarnaik AP
    Ann Clin Lab Sci; 1996; 26(1):60-3. PubMed ID: 8834361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublethal hemorrhagic shock reduces tumor necrosis factor-alpha-producing capacity in different cell compartments.
    Flohé S; Ackermann M; Reuter M; Nast-Kolb D; Schade FU
    Eur Cytokine Netw; 2000 Sep; 11(3):420-6. PubMed ID: 11022127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.